Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
PR Newswire

News of the day

Movianto Supports Pinnacle Biologics' Market Entry Into Europe

4th September 2008 STUTTGART, Germany, September 4 /PRNewswire/ -- Pinnacle Biologics has appointed Movianto to provide exclusive logistics and distribution services to support the launch of the drug Ethyol(R) in several European markets. As one of the leading European providers of distribution and logistics services for the pharmaceutical, biotechnology and healthcare industry, Movianto through its pan-European network of ten subsidiaries offers an ideal infrastructure and services portfolio along the whole... more

Merck Serono and Ablynx Enter Into an Agreement to Co-Discover and Co-Develop Nanobodies(R)

4th September 2008 GENEVA, September 4 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that it has entered into an agreement with Ablynx (Euronext Brussels: ABLX), to co-discover and co-develop Nanobodies(R) against two targets in oncology and immunology. The agreement includes an upfront cash payment to Ablynx of EUR10 million. Nanobodies(R) are a new class of therapeutic proteins that contain the unique structural and functional properties of naturally-occurring... more

Merck Serono and ZymoGenetics Restructure Partnership

3rd September 2008 GENEVA, Switzerland, September 3 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and ZymoGenetics, Inc. (NASDAQ: ZGEN), Seattle, United States, today announced a restructuring of their partnership. With respect to the ongoing development of atacicept, an investigational drug for the treatment of various autoimmune diseases and B-cell malignancies, ZymoGenetics has exercised its contractual right to convert to a worldwide royalty license. By making this election,... more
Joint Ventures RSS feed

PR Newswire search

Search the PR Newswire by keyword. Alternatively our advanced search allows you to query by category.
Category
To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

More recent news

Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
3rd September 2008 MUNICH, Germany, September 3 /PRNewswire/ -- A sub-analysis of the TRITON-TIMI 38 clinical trial showed that treatment with prasugrel compared with clopidogrel significantly reduced the risk of new...

San Francisco Bay Area Cell Analysis Company Forges Partnership With Hudson Control Group as First Step in Automation Initiative to Support Drug Discovery Research
28th August 2008 HAYWARD, California, August 28 /PRNewswire/ -- Guava Technologies, Inc. announced the commencement of an agreement with Hudson Control Group to provide drug discovery researchers with an...

Peakdale Molecular Launches AssayReady4U(TM) in Collaboration With ChemPrintCo LLC
27th August 2008 CHAPEL-EN-LE-FRITH, England and MILPITAS, California, August 27 /PRNewswire/ -- Peakdale Molecular Ltd (CHAPEL-EN-LE-FRITH, UK) a leading provider in specialist chemistry services to the...

Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA
27th August 2008 SAN DIEGO and INDIANAPOLIS, August 27 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) in a conference call today provided context and...

Genmab Reaches Fifth Milestone in Ofatumumab Collaboration
21st August 2008 COPENHAGEN, August 21 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today it has reached the fifth milestone for ofatumumab (HuMax-CD20(R)) under the terms of its collaboration with GlaxoSmithKline...

Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events
21st August 2008 TOKYO and INDIANAPOLIS, August 21 /PRNewswire/ -- A new, pre-specified analysis of the landmark Phase III head-to-head TRITON-TIMI 38 study showed patients who took prasugrel for acute...

Bavarian Nordic Announces Partnership With National Cancer Institute in the US and Obtains Rights to a New Vaccine Candidate
13th August 2008 KVISTGARD, Denmark, August 13 /PRNewswire/ -- Bavarian Nordic's US subsidiary, BN ImmunoTherapeutics has entered into a scientific partnership with the National Cancer Institute (NCI) in the...

Bavarian Nordic Announces Partnership With National Cancer Institute in the US and Obtains Rights to a New Vaccine Candidate
13th August 2008 KVISTGARD, Denmark, August 13 /PRNewswire/ -- Bavarian Nordic's US subsidiary, BN ImmunoTherapeutics has entered into a scientific partnership with the National Cancer Institute (NCI) in the...

Banque Centrale Populaire Consolidates Activity Abroad With New Trade Finance Solutions From Misys
5th August 2008 LONDON, August 5 /PRNewswire/ -- Banque Centrale Populaire (BCP), one of the largest banks in Morocco, has strengthened its trade finance offer to corporates with the new trade finance solutions from...

GeoVax Partners with Vivalis for Use of Its Revolutionary EBx(R) Technology to Manufacture Its MVA HIV/AIDS Vaccine
22nd July 2008 ATLANTA and NANTES, France, July 22 /PRNewswire/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1...

Comprehensive Care International and SHI Consulting Announce Partnership for Effective Integration of Research Into Clinical Planning and Design
21st July 2008 TORONTO, July 21 /PRNewswire/ -- Comprehensive Care International (CCI) and SHI Consulting Inc. (SHI) outlined their vision to create a sustainable operational advantage for hospitals worldwide....

Physicians Practice and Nevada Cancer Institute Partner to Improve Patient Care
15th July 2008 BALTIMORE, July 15 /PRNewswire/ -- Physicians and patients of community-based medical practices in Nevada and SW Utah will benefit from a new partnership between Physicians Practice(R), America's...

Ingenuity Systems and CHDI Announce Multi-Year Deal for Disease-Specific Knowledge Platform
15th July 2008 REDWOOD CITY, California, July 15 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life science researchers, and CHDI Foundation, Inc., a non-profit...

AMT Starts Collaboration With St. Jude Children's Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy
15th July 2008 AMSTERDAM, The Netherlands, July 15 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced the start of a collaboration with...

Cellectis and Regeneron Sign an Agreement Over the use of Homologous Recombination Technology
3rd July 2008 BIOCITECH, France, July 3 /PRNewswire/ -- Cellectis SA today announced the signature of an agreement with Regeneron Pharmaceuticals, Inc. over the use of Cellectis' patents covering certain uses of...

The Institut de la Vision and Iris Pharma Join Forces to Strengthen the Bond Between the Private and Public Sectors, and Between Industry and Academic Research
3rd July 2008 NICE, France, July 3 /PRNewswire/ -- The Institut de la Vision, a research center exclusively dedicated to eye diseases, has been the industry's benchmark on vision-related issues since its opening...

Genmab Reaches Milestone in Ofatumumab Collaboration
30th June 2008 COPENHAGEN, June 30 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today it has reached a development milestone for ofatumumab (HuMax-CD20(R)) under the terms of its collaboration with...

Elsevier Announces Agreement With Portico
26th June 2008 AMSTERDAM, June 26 /PRNewswire/ -- Elsevier, a leading publisher of scientific, technical and medical (STM) information, today announced an agreement with Portico, a not-for-profit digital...

Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
25th June 2008 REHOVOT, Israel and JERSEY CITY, New Jersey, June 25 /PRNewswire/ -- Rosetta Genomics, Ltd. (Nasdaq: ROSG), announced today a collaboration with the Rabin Medical Center in Israel to...

ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
18th June 2008 LEUVEN, Belgium, LUND, Sweden and BASEL, Switzerland, June 18 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR) and BioInvent International AB (Nordic Exchange: BINV) announce that they have...

MSD Signs Partnership With BMJ Group
17th June 2008 BERLIN, June 17 /PRNewswire/ -- The pharmaceutical company MSD (known as Merck Sharp & Dohme Limited in the UK and Merck & Co., Inc. in the US) and BMJ (British Medical Journal) Group today announced...

AmVac AG Begins Research Cooperation With Bayer Research Laboratory Inaugurated in Catania
12th June 2008 ZUG, Switzerland and CATANIA, Italy, June 12 /PRNewswire/ -- AmVac AG, a Swiss biopharmaceutical company based in Zug, is starting its first research cooperation program with Bayer Innovation GmbH...

Mentice Initiates Collaboration With Pieter Stella as Clinical Advisor
12th June 2008 GOTHENBURG, June 12 /PRNewswire/ -- Mentice, a leading developer of medical simulation solutions, today announces collaboration with Dr. Pieter Stella as Clinical Advisor to Mentice. Dr Stella will...

Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
11th June 2008 TOKYO and NEW DELHI, India, June 11 /PRNewswire/ -- Daiichi Sankyo Company, Limited (TSE: 4568.JP) ("Daiichi Sankyo"), one of the largest pharmaceutical companies in Japan, and Ranbaxy...

Merck Serono Strengthens its Prescription Medicines Portfolio in Latin America
10th June 2008 GENEVA, Switzerland, June 10 /PRNewswire/ -- Merck Serono (NYSE: SRA), a division of Merck KGaA, Darmstadt, Germany, announced today the signing of a distribution agreement with Bristol-Myers Squibb...

Ingenuity Systems Announces Multi-Year Agreement With Boehringer Ingelheim
3rd June 2008 REDWOOD CITY, California, June 3 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life science researchers, announced the signing of a four year agreement...

ThromboGenics and BioInvent Report Positive Phase I Results for Anti-PlGF Cancer Therapeutic TB-403
3rd June 2008 LEUVEN, Belgium and LUND, Sweden, June 3 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International AB (Nordic Exchange: BINV) today reported that...

Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Würzburg, Germany
29th May 2008 AMSTERDAM, May 29 /PRNewswire/ -- Biopharmaceutical company Kiadis Pharma announces today the clinical development collaboration for its lead product ATIR(TM) with Dr. Stephan Mielke and Professor...

World Gastroenterology Organisation and Danone launch Global Campaign to Improve Digestive Health
29th May 2008 LONDON, May 29 /PRNewswire/ -- Today, on the occasion of World Digestive Health Day (WDHD), the World Gastroenterology Organisation (WGO) has launched a year-long campaign titled 'Optimum Health and...

AMT's Cooperative Research and Development Agreement with NIH to Boost Production Capacity
26th May 2008 AMSTERDAM, The Netherlands, May 26 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it obtained a Cooperative...

University Hospitals Case Medical Center, Cleveland, USA and Cardialysis BV, Rotterdam, the Netherlands Enter Strategic Alliance to Found Cardialysis Cleveland
9th May 2008 CLEVELAND, Illinois and ROTTERDAM, The Netherlands, May 9 /PRNewswire/ -- University Hospitals Case Medical Center and Cardialysis BV today announced that the Companies have the intention to found...

NTT Europe Online and Sun Start-Up Essentials Help Deliver Glasses Direct to Customers
25th April 2008 LONDON, April 25 /PRNewswire/ -- Glasses Direct has signed up as a member and customer of the hosting offer in the Sun Start-Up Essentials program in the UK. As part of the program, the online...

CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
24th April 2008 LAS VEGAS, April 24 /PRNewswire/ -- CardioVascular BioTherapeutics, Inc. (OTC Bulletin Board: CVBTE) has entered into an agreement with Mr. Phillip Frey Jr. to form Cardio Derma Clinical Partners...

SCHOTT Forms Pharmaceutical Joint Venture in India
24th April 2008 MAINZ, Germany and MUMBAI, India, April 24 /PRNewswire/ -- SCHOTT AG and KAISHA Manufacturers Private Ltd., an Indian company, announce the formation of a joint venture, SCHOTT KAISHA Private Ltd....

ESBATech's Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications
24th April 2008 ZURICH, Switzerland, April 24 /PRNewswire/ -- ESBATech AG, a leading developer of antibody fragment therapeutics, today announced the initiation of Phase I clinical development of the company's lead...

Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement
22nd April 2008 AMSTERDAM, Netherlands and SANTA CLARA, California, April 22 /PRNewswire/ -- Agendia BV, a world leader in the rapidly evolving field of molecular diagnostics, and Agilent Technologies, Inc. (NYSE:...

Global Med Technologies(R), Inc. and Cerner Announce Strategic Alliance
9th April 2008 DENVER, April 9 /PRNewswire/ -- Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today announced that its Wyndgate...

Health Unions React to NHS Pay Offer
8th April 2008 LONDON, April 8 /PRNewswire/ -- Health unions representing 200,000 healthcare scientists, health visitors, speech and language therapists, clinical psychologists, chaplains, mental health nurses,...

Shire and TAP Agree to Co-promote LIALDA(TM) (Mesalamine), the First Oral Once-Daily Mesalamine for Patients With Active, Mild to Moderate Ulcerative Colitis
26th March 2008 BASINGSTOKE, England and PHILADELPHIA, March 26 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today a co-promotion agreement with...

Perot Systems and ChinaSoft to Pursue Chinese Healthcare Opportunities
18th March 2008 PLANO, Texas, March 18 /PRNewswire/ -- Perot Systems Corporation (NYSE: PER) and ChinaSoft International (HK8216) today announced that they have agreed to cooperatively develop mutually beneficial...

Misys and Allscripts Create a Leader in Healthcare Software
18th March 2008 LONDON, March 18 /PRNewswire/ -- In a video interview Mike Lawrie, CEO Misys, and Glen Tullman, CEO Allscripts, talk about the combination of Misys Healthcare and Allscripts to create a leader in US...

Misys and Allscripts Create a Leader in Healthcare Software
18th March 2008 LONDON, March 18 /PRNewswire/ -- In a video interview Mike Lawrie, CEO Misys, and Glen Tullman, CEO Allscripts, talk about the combination of Misys Healthcare and Allscripts to create a leader in...

Spize TV Partners Pyramid Saimira
14th March 2008 LONDON, March 14 /PRNewswire/ -- - Launches DTH Services Across Europe, North Africa & Middle East

Partnering consultation free of charge
Stem Cell Conference
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us